AGIOS PHARMACEUTICALS, INC. Insider Trading for August 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for August 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 10,000 | 3,025 | 275,022 | |
| Aug 21 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 10,000 | 3,025 | 141,835 | 131.8 K to 141.8 K (+7.59 %) |
| Aug 19 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 20,000 | 6,050 | 285,022 | |
| Aug 19 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 92.24 | 20,000 | 1,844,800 | 131,835 | 151.8 K to 131.8 K (-13.17 %) |
| Aug 19 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 20,000 | 6,050 | 151,835 | 131.8 K to 151.8 K (+15.17 %) |
| Aug 19 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 95.69 | 2,426 | 232,144 | 152,706 | 155.1 K to 152.7 K (-1.56 %) |
| Aug 19 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 95.69 | 2,426 | 232,144 | 152,706 | 155.1 K to 152.7 K (-1.56 %) |
| Aug 19 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 94.18 | 2,426 | 228,481 | 155,132 | 157.6 K to 155.1 K (-1.54 %) |
| Aug 19 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 94.21 | 2,426 | 228,553 | 155,132 | 157.6 K to 155.1 K (-1.54 %) |
| Aug 12 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 5,500 | 174,020 | 296,380 | |
| Aug 12 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 100.00 | 5,500 | 550,000 | 34,070 | 39.6 K to 34.1 K (-13.90 %) |
| Aug 12 2015 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 5,500 | 174,020 | 39,570 | 34.1 K to 39.6 K (+16.14 %) |
| Aug 10 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 10,000 | 3,025 | 305,022 | |
| Aug 10 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 10,000 | 3,025 | 131,835 | 121.8 K to 131.8 K (+8.21 %) |
| Aug 05 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 31.64 | 7,299 | 230,940 | 871,320 | |
| Aug 05 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 701 | 212 | 878,619 | |
| Aug 05 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 110.60 | 8,000 | 884,800 | 232,272 | 240.3 K to 232.3 K (-3.33 %) |
| Aug 05 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 31.64 | 7,299 | 230,940 | 240,272 | 233 K to 240.3 K (+3.13 %) |
| Aug 05 2015 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 701 | 212 | 232,973 | 232.3 K to 233 K (+0.30 %) |